Variant Summary
- Also known as
- KANK1-NTRK2
- HGVS
- —
- Variant Type(s)
- transcript_fusion
- Evidence Items
- 6
Evidence Level Distribution
Level C: 6
Evidence Items
Showing CIViC evidence rows where gene = KANK1::NTRK2 and variant = Fusion.
| Level | Type | Direction | Significance | Disease | Drugs | Rating |
|---|---|---|---|---|---|---|
| C | Predictive | Supports | Sensitivity/Response | Anaplastic Ependymoma | Larotrectinib | 4 |
| C | Predictive | Supports | Sensitivity/Response | Glioblastoma | Larotrectinib | 3 |
| C | Oncogenic | Supports | Oncogenicity | Sarcoma | 2 | |
| C | Diagnostic | Supports | Positive | Pilocytic Astrocytoma | 2 | |
| C | Oncogenic | Supports | Oncogenicity | Brain Glioblastoma Multiforme | 1 | |
| C | Predictive | Supports | Sensitivity/Response | Ganglioneuroblastoma | Entrectinib | 1 |